Welcome to our dedicated page for Innospec news (Ticker: IOSP), a resource for investors and traders seeking the latest updates and insights on Innospec stock.
Innospec Inc. reports recurring developments across its global specialty chemicals business, including earnings releases, segment performance and capital actions for its NASDAQ-listed common stock. Company updates commonly discuss Performance Chemicals, which serves personal care, home care, agrochemical, mining, construction and industrial markets; Fuel Specialties, which supplies additives for diesel, jet, marine, fuel oil, renewable fuel and other applications; and Oilfield Services, which provides chemicals for drilling, completion, production and related oil and gas uses.
News about IOSP also covers margin initiatives, new technology commercialization, plant and operating disruptions, dividends, share repurchase authorizations and selected sustainability or social partnership programs tied to its operating businesses.
Innospec Inc. (NASDAQ: IOSP) reported strong Q3 2021 results, with total revenues reaching $376.1 million, a 42% increase year-over-year. GAAP EPS was 94 cents, while adjusted non-GAAP EPS hit $1.15, up from 71 cents the previous year. Operating income surged 44% to $23.4 million. The company declared a 12% increase in its annual dividend, totaling $1.16 per share. Performance Chemicals led growth with record sales of $132.8 million. However, cash flow was impacted by rising working capital needs due to supply chain disruptions.
Innospec Inc. (NASDAQ: IOSP) will announce its third quarter 2021 earnings on November 2, 2021, post-market. CEO Patrick S. Williams and CFO Ian Cleminson will discuss the results in a conference call on November 3, 2021, at 10:00 a.m. ET. Investors can access the call via phone or through a live audio webcast on Innospec's website. A replay will be available from November 4 to November 11, 2021.
Innospec operates in the specialty chemicals sector, providing services including fuel additives and performance chemicals across various industries worldwide.
Innospec (NASDAQ: IOSP) has published its 2020 Responsible Business Report, highlighting significant achievements in sustainability and corporate responsibility. Key metrics include a 46% reduction in absolute scope 1 and 2 greenhouse gas emissions, with all manufacturing facilities now using 100% renewable electricity. The company earned the EcoVadis Gold Medal for sustainability and delivered US$704,000 in social value to 155 charities. Notable investments in production capacity were made in North Carolina and Texas, alongside the establishment of a new technology center in Salisbury.
Innospec Inc. (NASDAQ: IOSP) reported strong second-quarter results for 2021, with total revenues reaching $354.5 million, a 45% increase from the previous year. The company's net income improved to $22.4 million or 90 cents per share. Adjusted non-GAAP EPS was $1.30, up from a loss of 18 cents a year ago. Performance Chemicals and Fuel Specialties drove growth, with record sales in Performance Chemicals at $128.2 million up 34%. Despite a small operating cash outflow, the company maintains a healthy liquidity position with $94.2 million in net cash.
Innospec Inc. (NASDAQ: IOSP) will release its second quarter 2021 earnings results on August 3, 2021, after market close. An interactive conference call will take place on August 4, 2021, at 10:00 a.m. ET, featuring CEO Patrick S. Williams and CFO Ian Cleminson. Investors can access the call via phone or through a webcast on the company’s website. A replay will be available from August 4 through August 11, 2021. Innospec, a specialty chemicals company with operations in 23 countries, focuses on fuel additives, oilfield services, and performance chemicals.
Innospec is expanding its production capacity to meet rising demand for its sustainable surfactants. Following a March 2021 expansion at its Salisbury, NC site, the company approved an additional $10 million investment for further capacity, set to begin operation by early 2022. These enhancements aim to improve production capabilities for the Performance Chemicals sector, which serves key markets like personal care and homecare. The investments align with Innospec's sustainability goals, enhancing supply chain efficiency and reducing carbon footprint.
Innospec (NASDAQ: IOSP) has partnered with Unilever to advance non-animal testing methods for assessing product safety. This collaboration addresses the European Chemicals Agency's (ECHA) request for new animal tests on long-used ingredients. Innospec aims to utilize innovative risk assessment techniques that prioritize human relevance and worker safety. The partnership reflects the companies' commitment to responsible chemical stewardship and sustainability. Bruce McDonald, Innospec's President, emphasized the importance of this initiative in meeting long-term social goals.
Innospec (NASDAQ: IOSP) has officially broken ground on a new 20,000 sq. ft Performance Chemicals technology center in Salisbury, NC, aimed at enhancing global R&D and product development. This state-of-the-art facility will feature ten laboratories that cater to the personal care, home care, agrochemicals, and industrial sectors. The move reflects Innospec's commitment to innovation and sustainability, with plans to expand its technical team in anticipation of the facility's completion. The investment supports its objectives of delivering collaborative and innovative solutions to customers.
Innospec reported record sales and operating income for Performance Chemicals in Q1 2021, achieving total revenues of $339.6 million, a 9% decrease year-over-year. GAAP EPS stood at $0.94, while adjusted non-GAAP EPS was $1.06. The company generated strong cash flow, ending the quarter with $116.6 million in net cash. A semi-annual dividend of $0.57 was declared, marking a 10% increase. Despite lower revenues in Fuel Specialties and Oilfield Services, the company is optimistic about recovery and ongoing capital investments.
Innospec made an all-share approach to acquire Elementis at 160p per share, with a 50% cash alternative, which was rejected on April 9, 2021. Following this, Innospec ceased its acquisition efforts on April 15, 2021. The proposed merger was believed to create significant benefits for shareholders due to expected synergies and a higher valuation. Innospec emphasizes its commitment to value creation for its shareholders while maintaining a prudent capital structure. This announcement adheres to Rule 2.8 of the Takeover Code, reserving rights to bypass restrictions under certain conditions.